Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2005

View Archived Issues

Potent and selective CCR3 antagonist DPC-168 from BMS enters phase I

Antioxidants prevent doxorubicin-induced cardiotoxicity without altering anticancer effect

GABA-B antagonist exhibits antidepressant effects

Psoriasin, a newly discovered protein, protects human skin from E. coli infection

Gene transfer rapidly immunizes mice against anthrax

Safety data studied for Reminyl

Enrollment completed in phase III HARS study of Serostim

TURNS to test Org-24448 for enhancing cognition in schizophrenic patients

Pharmos receives milestone for Zylet launch

Helix BioMedix in antiinfectives collaboration with Smith & Nephew

Sorin completes enrollment in JUPITER II study of Janus Carbostent

Approval for phase I trial of AL-108 for Alzheimer's

France requests further information on Exanta for AF

BioTie inlicenses BKT-104

Canadian clearance for phase I trial of VP-025 for neuroinflammatory disease

Schering AG and Novartis enter oncology copromotion agreement for PTK/ZK

Sulfatides enhance platelet and platelet-leukocyte aggregation

Peregrine gains access to Merck KGaA's protein expression technology

Lead antibodies identified under SOA-002 project collaboration

Teikoku Hormone and Grelan make progress in merger

Yamanouchi presents novel series of antidiuretic compounds

Taisho scientists prepare and test agents for obesity

Kyowa Hakko discloses agents for diabetes and related complications

New compounds for lipoprotein disorders described in patent literature

Scientists at Kowa identify PPARalpha agonists for hyperlipidemia, atherosclerosis, etc.

MAP kinase inhibitors in early development at Ono

Insulin sensitizers described in a patent

Cardiac remodeling interrupted, reversed by sildenafil

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026